Jianhui Information Announcement: The company plans to acquire a 38% stake in Boke Guoxin (Wuhan) Technology Co., Ltd. held by Zhou Xiaoping, Ze Pu Investment, Boke Medical Trust, and Boke Guoxin for 73.7102 million RMB. Before the transaction, Jianhui Information held a 32% stake in the target company; after the transaction, the shareholding will increase to 70%, and the target company will become a controlling subsidiary and be consolidated into the financial statements. This transaction has been approved by the board of directors and does not constitute a related-party transaction or a major asset reorganization. The transaction price was negotiated based on a static P/E ratio of 13.54 times, with performance commitment clauses and installment payment arrangements set. The target company is expected to achieve an unaudited net profit of 14.3274 million RMB in 2025 and an audited net profit of 10.2924 million RMB in 2024.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Jianhui Information: Plans to acquire a 38% stake in Boke Guoxin (Wuhan) Technology Co., Ltd. for 73.71 million yuan
Jianhui Information Announcement: The company plans to acquire a 38% stake in Boke Guoxin (Wuhan) Technology Co., Ltd. held by Zhou Xiaoping, Ze Pu Investment, Boke Medical Trust, and Boke Guoxin for 73.7102 million RMB. Before the transaction, Jianhui Information held a 32% stake in the target company; after the transaction, the shareholding will increase to 70%, and the target company will become a controlling subsidiary and be consolidated into the financial statements. This transaction has been approved by the board of directors and does not constitute a related-party transaction or a major asset reorganization. The transaction price was negotiated based on a static P/E ratio of 13.54 times, with performance commitment clauses and installment payment arrangements set. The target company is expected to achieve an unaudited net profit of 14.3274 million RMB in 2025 and an audited net profit of 10.2924 million RMB in 2024.